相关实验视频

Updated: Jan 10, 2026

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo

Published on: July 25, 2025

固体瘤中的CAR巨细胞:承诺,进展和前景

Maram Alrehaili¹, Pedro Silva Couto¹, Rana Khalife¹

¹Department of Biochemical Engineering, Advanced Centre for Biochemical Engineering, University College London, London, UK.

NPJ precision oncology

|November 27, 2025

概括

化学抗原受体巨细胞 (CAR-Ms) 通过重塑瘤微环境,显示出对固体瘤免疫疗法的希望. 克服细胞扩张和工程方面的挑战是作为现成疗法的临床成功的关键.

科学领域:

免疫治疗是一种免疫疗法.
在瘤学瘤学.
细胞疗法细胞疗法

背景情况:

化学抗原受体巨细胞 (CAR-Ms) 是固体瘤的新兴免疫治疗方法.
CAR-Ms结合了先天的免疫功能与工程 CAR 信号,用于直接瘤向和微环境调制.
现有的基于细胞的疗法面临着局限性,这凸显了需要像CAR-Ms这样的新策略.

研究的目的:

审查对固体瘤CAR-M治疗的最新进展.
讨论支持CAR-M疗效的生物学理由和临床前发现.
确定成功临床翻译CAR-Ms所需的技术创新.

主要方法:

对CAR-M治疗的临床前和临床证据的审查.
在固体瘤中分析CAR-Ms的生物机制.
讨论CAR-M发展中的技术挑战和创新.

主要成果:

临床前和临床数据表明,对固体瘤的CAR-M疗法有显著的希望.
CAR-Ms显示出积极重塑瘤微环境的潜力.
通过CAR信号传输,CAR-M可以直接针对瘤细胞.

结论:

卡尔-M疗法是对固体瘤的一种有前途的免疫疗法策略.
临床翻译受到细胞扩张,基因工程和产品质量方面的挑战所阻碍.
技术创新对于开发CAR-Ms作为一种多功能,现成的免疫疗法,用于难以治疗的固体恶性瘤至关重要.

更多相关视频

A Macrophage-Tumor Spheroid Co-Invasion Assay

A Macrophage-Tumor Spheroid Co-Invasion Assay

Published on: January 24, 2025

Time-Lapse 2D Imaging of Phagocytic Activity in M1 Macrophage-4T1 Mouse Mammary Carcinoma Cells in Co-cultures

Time-Lapse 2D Imaging of Phagocytic Activity in M1 Macrophage-4T1 Mouse Mammary Carcinoma Cells in Co-cultures

Published on: December 14, 2019

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...